Fiche d'information compilée à partir de PubMed
Cette fiche a été compilée à partir de résumés PubMed (NIH) avec l'assistance d'une IA. Chaque affirmation factuelle est citée par un article PubMed réel (voir la liste des sources). Elle n'a pas encore été révisée par un humain — confirmez auprès d'un professionnel de santé avant utilisation.
Compilé à partir de 30 articles PubMed · modèle : gemma4:31b
Résumé
Contexte
Usages traditionnels
Composés actifs
Mécanisme d'action
Preuves cliniques
Oral administration of 3g of shallot per day (approx. 1.5 bulbs) as an adjuvant to cetirizine was studied for therapeutic effects [PMID:31421664]
Systematic review suggests shallot can be used as adjuvant therapy for these non-communicable diseases [PMID:35983491]
Topical application of shallot plant-derived nanovesicle hydrogels led to complete recovery of normal skin phenotype in murine models [PMID:40487455]
Aqueous extracts showed anti-growth activity in vitro against Jurkat and K562 tumor cell lines [PMID:22291731] and anti-carcinogenic properties against breast cancer in silico and in vitro [PMID:36331692]
Ethyl acetate fraction and essential oil demonstrated potent inhibitory activity against alpha-amylase, DPP-4, and PTP-1B in vitro [PMID:40820276]
Sécurité et effets indésirables
Synthèse des preuves
Sources PubMed
- 1.PMID: 35983491 (2022) — Therapeutic Uses and Pharmacological Properties of Shallot (Allium ascalonicum): A Systematic Review. · Frontiers in nutrition
- 2.PMID: 35684272 (2022) — Phytochemical Constitution, Anti-Inflammation, Anti-Androgen, and Hair Growth-Promoting Potential of Shallot (Allium ascalonicum L.) Extract. · Plants (Basel, Switzerland)
- 3.PMID: 31421664 (2022) — Antiallergic activities of shallot (Allium ascalonicum L.) and its therapeutic effects in allergic rhinitis. · Asian Pacific journal of allergy and immunology
- 4.PMID: 22291731 (2011) — Anticancer and anti-inflammatory activities of shallot (Allium ascalonicum) extract. · Archives of medical science : AMS
- 5.PMID: 12236699 (2002)